Mobilising novel finance models for health promotion and disease prevention
Mobilising novel finance models for health promotion and disease prevention
批准号:
10061251
负责人:
金额:
$36.6万
依托单位:
依托单位国家:
英国
项目类别:
EU-Funded
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
从中长期来看,政府必须提供额外预算资源的财政空间将缩小,包括医疗保健。我们的回应是,最好是先发制人,而不是修复,即鼓励为促进健康和预防疾病提供资金的新方式。融资解决方案是智能投资。这意味着分担风险和资源,在卫生生态系统内的多个层面进行大规模投资,从而产生可持续的回报和局部效益。具体目标是:1。利用现有证据,加强智能投资的框架和沟通。评估和提高组织在区域试验台测试SCI模型的准备程度。开发和测试与智能投资兼容的商业模式。开发和测试新的金融模型,以确定哪些业务模型符合预先定义的附带条件,以提供智能的投资。开发和测试一个原型协作平台,用于管理健康促进和预防方面的智能使能投资。通过跨学科的方法,我们校准和协调了3个主要工作流程:开发锚定概念的功能原型模型(智能容能投资)[WP2-4];在现实世界环境中进行迭代测试(ES、DE、SE、英国最初公开征集第二批过渡和欠发达地区),以显示在基于税收和保险的系统中的相关性[WP5-6];为大规模示范准备社会特许经营方案[WP7]。在这些工作流程的基础上,我们还将探索和测试基于平台的协作空间,以便有资源的公民小组和当地社区参与干预措施和服务的规划和投资决策。该项目产生了具体的成果和影响,进一步发展和吸收智能电容投资,颠覆了先进技术。
英文摘要
In the medium to longer-term, the fiscal space that governments have to provide additional budgetary resources will shrink, including for healthcare. Our response is that it is better to pre-empt rather than repair i.e., to incentivise new ways of financing health promotion and disease prevention. The financing solution is smart capacitating investment. This means sharing risks and resources to invest at scale across multiple levels within health ecosystems generating sustainable returns and localised benefits. The specific objectives are: 1. Draw on available evidence to strengthen how smart capacitating investment is framed and communicated 2. Assess and enhance organisational readiness for testing SCI models in the regional test-beds 3. Develop and test business models that are compatible with smart capacitating investment 4. Develop and test novel finance models to determine which of the business models align with pre-defined contingencies for delivering smart capacitating investment 5. Develop and test a prototype collaborative platform for governing smart capacitating investment in health promotion and prevention. With an interdisciplinary approach we calibrate and harmonise 3 main work streams: developing functional prototype models of the anchoring concept (smart capacitating investment) [WP2-4]; iterative testing in real world environments (ES,DE,SE,UK initially with an Open Call for a 2nd tranche of transition and less developed regions) to show relevance in tax and insurance-based systems [WP5-6]; preparing a social franchising package for large-scale demonstration [WP7]. Underpinning these workstreams, we will also explore and test platform-based collaborative spaces for the involvement of resourced citizen panels and local communities in planning and investment decisions for interventions and services. The project generates concrete outcomes and impacts for further development and uptake of smart capacitating investment that disrupts state-of-the-art.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
miR-2796和novel_13靶向磷脂酶C基因调控Q烟粉虱高温耐受性的分子机制
-
批准号:32402377
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:戴恬美
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位: